Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Contraception study supports convenience, simplicity

27.02.2004


Women who used the once-a-week birth control patch, ORTHO EVRA® (norelgestromin/ethinyl estradiol transdermal system), were more likely to use their medication as directed than women who took a birth control pill, according to a study published in the current issue of Contraception.

"It’s not always easy, but it is very important for women using any birth control pill to take it at the same time every day to prevent unplanned pregnancy," said Vanessa Cullins, M.D. FACOG. "What’s exciting is that this study shows that the birth control patch is convenient and simple to use, and may be a better birth control option for women."

Oral birth control pills must be taken consistently and correctly to be effective, however an estimated 15 percent of oral birth control users say it is difficult to do so with the Pill. Inconsistent or incorrect use, i.e., missing one or more pills per cycle, can increase the risk of unplanned pregnancy and lead to abnormal bleeding, which is the leading cause of unscheduled physician visits. In the study, previously published Phase III data were analyzed to further explore compliance differences between ORTHO EVRA and an oral contraceptive. These results showed that the percentage of cycles with "perfect dosing," a measure of correct dosing of a birth control method, was significantly higher with the patch (88.7 percent) than oral contraceptives (79.2 percent).



Investigators pooled these data with new findings, which showed:


ORTHO EVRA users achieved perfect dosing in nearly 90 percent of total cycles. These rates were consistently high across all age groups.
Perfect dosing cycles were associated with significantly better contraceptive efficacy (p = .007) than imperfect dosing cycles, i.e., missing a dose and doubling up the next day.
ORTHO EVRA is indicated for the prevention of pregnancy. ORTHO EVRA is not for everyone. Women should speak with their healthcare professional about which birth control method is right for them.

The contraceptive patch contains hormones similar to those in birth control pills. Hormonal contraceptives are not for everyone. Most side effects of the contraceptive patch are not serious and those that are occur infrequently. Serious risks that can be life threatening includes blood clots, stroke or heart attacks, which are increased if you smoke cigarettes.

Cigarette smoking increases the risk of serious cardiovascular side effects, especially if you are over 35. Women who use hormonal contraceptives are strongly advised not to smoke. Some women should not use the contraceptive patch, including women who have blood clots, certain cancers, a history of heart attack or stroke, as well as those who are or may be pregnant. The contraceptive patch does not protect against HIV or other sexually transmitted diseases.


ORTHO EVRA was developed by Johnson & Johnson Pharmaceutical Research & Development, L.L.C. and is marketed by Ortho-McNeil Pharmaceutical, Inc. Ortho-McNeil is a pioneer and leader in contraception and women’s health care, offering the broadest range of prescription birth control options, including the first transdermal contraceptive patch, ten birth control pills, and diaphragms. The company also markets prescription pharmaceutical products in other therapeutic categories, including infectious disease, central nervous system, pain treatment, urology and migraine headache. For more information, visit www.orthoevra.com or www.ortho-mcneil.com.

Kevin Pchola | EurekAlert!
Further information:
http://www.orthoevra.com
http://www.ortho-mcneil.com

More articles from Social Sciences:

nachricht Fixating on faces
26.01.2017 | California Institute of Technology

nachricht Internet use in class tied to lower test scores
16.12.2016 | Michigan State University

All articles from Social Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>